1. Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
- Author
-
Stephanie Mitri, Dani Osman, George Khoury, Gregory Nicolas, Elliott Koury, Christian Saliba, Julien-Sami Atef El Sayegh, Linda Rached, and Lea Nehme
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Fever ,Chronic lymphocytic leukemia ,030106 microbiology ,Mucocutaneous zone ,Antiprotozoal Agents ,Spleen ,Medical Oncology ,03 medical and health sciences ,Immunocompromised Host ,Amphotericin B ,parasitic diseases ,medicine ,Humans ,Methylprednisolone Hemisuccinate ,Glucocorticoids ,Aged ,biology ,business.industry ,Leishmaniasis ,General Medicine ,Articles ,medicine.disease ,Leishmania ,biology.organism_classification ,Pancytopenia ,Dermatology ,Leukemia, Lymphocytic, Chronic, B-Cell ,Laparoscopes ,Leukemia ,medicine.anatomical_structure ,Visceral leishmaniasis ,General Surgery ,Leishmaniasis, Visceral ,business - Abstract
Patient: Male, 73 Final Diagnosis: Leishmania Symptoms: Fever Medication: — Clinical Procedure: — Specialty: Oncology Objective: Unusual clinical course Background: Leishmaniasis is a parasitic infection spread by the bite of infected sand flies that are usually present in the Middle East, Africa, and some parts of Asia and Europe. Leishmaniasis manifests in 3 different forms: Visceral (also known as Kala Azar), which is the most serious type; cutaneous, which is the most common type; and mucocutaneous. The symptoms of this infection range from a silent infection to fever, enlargement of the liver and spleen, weight loss, and pancytopenia. Case Report: In this case report, we discuss a 73-year-old man known to have chronic lymphocytic leukemia (CLL), presenting with unremitting fever and who to our surprise was found to have Kala Azar. Conclusions: Early diagnosis and treatment are very important in treating visceral leishmaniasis. While the conventional treatment in immunocompromised patients is liposomal amphotericin B, our patient responded to corticosteroids.
- Published
- 2018